Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value: $714M (100.0% shares, 0.0% debt)

Holdings (29)

INGN INOGEN INC 33.2%
Value $237M Shares 3,549,321 Share Price $66.76 * Est. Cost/Share $17.78 Unrealized @ Report Date +328.2%
MIST MILESTONE PHARMACEUTICALS INC 10.2%
Value $72.61M Shares 2,674,470 Share Price $27.15 * Est. Cost/Share $20.62 Unrealized @ Report Date 0.0%
AAPL APPLE INC 7.4%
Value $53M Shares 267,788 Share Price $197.92 * Est. Cost/Share $46.62 Unrealized @ Report Date 0.0%
CABO CABLE ONE INC 7.4%
Value $52.7M Shares 45,000 Share Price $1171.00 * Est. Cost/Share $833.27 Unrealized @ Report Date +20.6%
— MORPHIC HLDG INC 7.3%
Value $52.43M Shares 2,645,446 Share Price $19.82 Est. Cost/Share $19.82 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 4.1%
Value $28.93M Shares 2,317,870 Share Price $12.48 Est. Cost/Share $13.98 Unrealized @ Report Date -9.2%
GKOS GLAUKOS CORP 3.2%
Value $22.62M Shares 300,000 Share Price $75.40 * Est. Cost/Share $30.48 Unrealized @ Report Date +135.4%
SIBN SI BONE INC 2.5%
Value $18.16M Shares 892,684 Share Price $20.34 * Est. Cost/Share $18.92 Unrealized @ Report Date -9.3%
— SEASPINE HLDGS CORP 2.4%
Value $17.33M Shares 1,308,037 Share Price $13.25 Est. Cost/Share $12.38 Unrealized @ Report Date —
— AERIE PHARMACEUTICALS INC 2.4%
Value $16.84M Shares 570,036 Share Price $29.55 Est. Cost/Share $54.30 Unrealized @ Report Date —
CRVS CORVUS PHARMACEUTICALS INC 2.3%
Value $16.53M Shares 4,420,516 Share Price $3.74 * Est. Cost/Share $13.03 Unrealized @ Report Date -69.9%
AKBA AKEBIA THERAPEUTICS INC 2.1%
Value $15M Shares 3,100,000 Share Price $4.84 * Est. Cost/Share $12.34 Unrealized @ Report Date -53.9%
— ENTASIS THERAPEUTICS HLDGS I 2.0%
Value $14.07M Shares 2,181,843 Share Price $6.45 Est. Cost/Share $10.88 Unrealized @ Report Date —
GLPG GALAPAGOS NV 1.8%
Value $12.57M Shares 97,481 Share Price $128.93 Est. Cost/Share $112.97 Unrealized @ Report Date —
— BLUEPRINT MEDICINES CORP 1.8%
Value $12.54M Shares 132,976 Share Price $94.33 Est. Cost/Share $87.08 Unrealized @ Report Date —
INSP INSPIRE MED SYS INC 1.5%
Value $10.61M Shares 175,000 Share Price $60.65 * Est. Cost/Share $42.52 Unrealized @ Report Date +26.8%
— NABRIVA THERAPEUTICS PLC 1.2%
Value $8.375M Shares 3,446,564 Share Price $2.43 Est. Cost/Share $7.20 Unrealized @ Report Date —
STIM NEURONETICS INC 1.0%
Value $7.291M Shares 582,798 Share Price $12.51 * Est. Cost/Share $28.78 Unrealized @ Report Date -50.9%
— MERUS N V 1.0%
Value $7.252M Shares 495,016 Share Price $14.65 Est. Cost/Share $7.99 Unrealized @ Report Date —
— SILK ROAD MEDICAL INC 1.0%
Value $7.027M Shares 145,000 Share Price $48.46 Est. Cost/Share $48.46 Unrealized @ Report Date —
KIDS ORTHOPEDIATRICS CORP 0.9%
Value $6.269M Shares 160,742 Share Price $39.00 * Est. Cost/Share $18.69 Unrealized @ Report Date +115.7%
SPRO SPERO THERAPEUTICS INC 0.8%
Value $5.363M Shares 465,983 Share Price $11.51 * Est. Cost/Share $12.04 Unrealized @ Report Date 0.0%
— ACCELERON PHARMA INC 0.7%
Value $4.918M Shares 119,708 Share Price $41.08 Est. Cost/Share $27.65 Unrealized @ Report Date —
— VERONA PHARMA PLC 0.5%
Value $3.778M Shares 740,740 Share Price $5.10 Est. Cost/Share $11.66 Unrealized @ Report Date —
CRNX CRINETICS PHARMACEUTICALS IN 0.5%
Value $3.375M Shares 135,009 Share Price $25.00 Est. Cost/Share $29.69 Unrealized @ Report Date -16.6%
— INTERSECT ENT INC 0.4%
Value $3.116M Shares 136,885 Share Price $22.76 Est. Cost/Share $22.76 Unrealized @ Report Date —
— FLEXION THERAPEUTICS INC 0.4%
Value $2.552M Shares 207,454 Share Price $12.30 Est. Cost/Share $12.30 Unrealized @ Report Date —
— UNUM THERAPEUTICS INC 0.2%
Value $1.24M Shares 473,441 Share Price $2.62 Est. Cost/Share $47.61 Unrealized @ Report Date —
PTGX PROTAGONIST THERAPEUTICS INC 0.0%
Value $289K Shares 23,901 Share Price $12.09 * Est. Cost/Share $11.06 Unrealized @ Report Date 0.0%